Suppr超能文献

Stability, variability, and treatment implications of the blood eosinophil count in Korean patients with chronic obstructive pulmonary disease.

作者信息

Lee Hyun Woo

机构信息

Division of Respiratory and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Korean J Intern Med. 2025 Jan;40(1):5-6. doi: 10.3904/kjim.2024.386. Epub 2025 Jan 1.

Abstract
摘要

相似文献

2
Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2023 Jun 12;18:1145-1153. doi: 10.2147/COPD.S401357. eCollection 2023.
3
Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma.
Allergol Int. 2023 Jul;72(3):402-410. doi: 10.1016/j.alit.2022.11.012. Epub 2022 Dec 29.
5
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
J Allergy Clin Immunol. 2018 Jun;141(6):2037-2047.e10. doi: 10.1016/j.jaci.2018.04.010. Epub 2018 Apr 28.
7
Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
Int J Chron Obstruct Pulmon Dis. 2017 Aug 17;12:2455-2464. doi: 10.2147/COPD.S129321. eCollection 2017.
8
Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
Lancet Respir Med. 2016 Sep;4(9):731-741. doi: 10.1016/S2213-2600(16)30148-5. Epub 2016 Jul 23.
9
The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2019 May 6;14:953-959. doi: 10.2147/COPD.S197361. eCollection 2019.
10

本文引用的文献

2
Risk factors of acute exacerbation and disease progression in young patients with COPD.
BMJ Open Respir Res. 2024 Jul 17;11(1):e001740. doi: 10.1136/bmjresp-2023-001740.
4
Validation of the Rome proposal for severity of acute exacerbation of chronic obstructive pulmonary disease.
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231172917. doi: 10.1177/17534666231172917.
5
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects.
Tuberc Respir Dis (Seoul). 2020 Jul;83(3):185-194. doi: 10.4046/trd.2020.0026. Epub 2020 Apr 29.
6
Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study.
Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):13-20. doi: 10.1016/j.arbres.2019.12.015. Epub 2020 Feb 13.
7
Inhaled corticosteroids in COPD: friend or foe?
Eur Respir J. 2018 Dec 13;52(6). doi: 10.1183/13993003.01219-2018. Print 2018 Dec.
8
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
J Allergy Clin Immunol. 2018 Jun;141(6):2037-2047.e10. doi: 10.1016/j.jaci.2018.04.010. Epub 2018 Apr 28.
9
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.01162-2017. Print 2017 Nov.
10
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验